AMPHENOL-A
AMPHENOL-A operates in Diversified Metals & Mining.
AMPHENOL-A (XPH) - Total Liabilities
Latest total liabilities as of September 2024: €10.06 Billion EUR
Based on the latest financial reports, AMPHENOL-A (XPH) has total liabilities worth €10.06 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
AMPHENOL-A - Total Liabilities Trend (2016–2023)
This chart illustrates how AMPHENOL-A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
AMPHENOL-A Competitors by Total Liabilities
The table below lists competitors of AMPHENOL-A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ucommune International Ltd
NASDAQ:UK
|
USA | $173.94 Million |
|
CORNING INC - Dusseldorf Stock Exchang
DU:GLW
|
Germany | €16.86 Billion |
|
Usha Martin Education & Solutions Limited
NSE:UMESLTD
|
India | ₹23.70 Million |
|
Pearl Polymers Limited
NSE:PEARLPOLY
|
India | ₹61.13 Million |
|
Permaju Industries Bhd
KLSE:7080
|
Malaysia | RM28.71 Million |
|
Movella Holdings Inc.
NASDAQ:MVLA
|
USA | $68.07 Million |
|
NEUROCRINE BIOSCNCE
BE:NB3
|
Germany | €816.10 Million |
Liability Composition Analysis (2016–2023)
This chart breaks down AMPHENOL-A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AMPHENOL-A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AMPHENOL-A (2016–2023)
The table below shows the annual total liabilities of AMPHENOL-A from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €8.10 Billion | -1.61% |
| 2022-12-31 | €8.23 Billion | -0.81% |
| 2021-12-31 | €8.30 Billion | +20.71% |
| 2020-12-31 | €6.88 Billion | +10.55% |
| 2019-12-31 | €6.22 Billion | +3.99% |
| 2018-12-31 | €5.98 Billion | +0.34% |
| 2017-12-31 | €5.96 Billion | +24.81% |
| 2016-12-31 | €4.78 Billion | -- |